Darunavir propylene glycolate is a solvate form of the HIV-1 protease inhibitor darunavir. It is used in antiretroviral therapy to block the HIV protease enzyme, preventing viral replication and aiding in the treatment of HIV infection. Its therapeutic use is listed as antivirals. The directory classifies it as a unknown/inactive API with a synthetic source/manufacturing origin. Other names for this substance include Prezista and Darunavir. Its PubChem CID is 71666654.
Darunavir propylene glycolate
| CAS No | 1447721-06-3 |
|---|---|
| Molecular Formula | C30H45N3O9S |
| Molecular Weight | 623.8 g/mol |
| Synonyms | [(3aS,4R,6aR)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamate;propane-1,2-diol |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Darunavir propylene glycolate is a solvate form of the HIV-1 protease inhibitor darunavir. It is used in antiretroviral therapy to block the HIV protease enzyme, preventing viral replication and aiding in the treatment of HIV infection.
The listed CAS number is 1447721-06-3.
The listed molecular formula is C30H45N3O9S.
The listed molecular weight is 623.8 g/mol.
[(3aS,4R,6aR)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamate;propane-1,2-diol.
The source lists Prezista and Darunavir.